Efficacy and safety of rituximab for relapsing-remitting multiple sclerosis: A systematic review and meta-analysis

Efficacy and safety of rituximab in relapsing-remitting multiple sclerosis: A systematic review and meta-analysis

Journal of Neuroimmunology ◽

10.1016/j.jneuroim.2020.577317 ◽

2020 ◽

Vol 347 ◽

pp. 577317

Author(s):

Xin Tian ◽

Chaoyang Chen ◽

Lingyun Ma ◽

Ran Wei ◽

Min Li ◽

...

Keyword(s):

Multiple Sclerosis ◽

Systematic Review ◽

Meta Analysis ◽

Efficacy And Safety ◽

Relapsing Remitting ◽

Comparative efficacy of disease-modifying therapies for patients with relapsing remitting multiple sclerosis: Systematic review and network meta-analysis

Multiple Sclerosis and Related Disorders ◽

10.1016/j.msard.2016.06.001 ◽

2016 ◽

Vol 9 ◽

pp. 23-30 ◽

Cited By ~ 59

Author(s):

Emer Fogarty ◽

Susanne Schmitz ◽

Niall Tubridy ◽

Cathal Walsh ◽

Michael Barry

Keyword(s):

Multiple Sclerosis ◽

Systematic Review ◽

Meta Analysis ◽

Comparative Efficacy ◽

Relapsing Remitting ◽

Disease Modifying ◽

Comparative Efficacy and Acceptability of Disease-Modifying Therapies in Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Network Meta-Analysis

SSRN Electronic Journal ◽

10.2139/ssrn.3266988 ◽

2018 ◽

Author(s):

Jian Zhang ◽

Yueling Zhang ◽

Jian Tang ◽

Jinglian Luo ◽

Jiefeng Luo ◽

...

Keyword(s):

Multiple Sclerosis ◽

Systematic Review ◽

Meta Analysis ◽

Comparative Efficacy ◽

Relapsing Remitting ◽

Disease Modifying ◽

Benefit–Risk of Therapies for Relapsing–Remitting Multiple Sclerosis: Testing the Number Needed to Treat to Benefit (NNTB), Number Needed to Treat to Harm (NNTH) and the Likelihood to be Helped or Harmed (LHH): A Systematic Review and Meta-Analysis

CNS Drugs ◽

10.1007/s40263-016-0377-9 ◽

2016 ◽

Vol 30 (10) ◽

pp. 909-929 ◽

Cited By ~ 14

Author(s):

Diogo Mendes ◽

Carlos Alves ◽

Francisco Batel-Marques

Keyword(s):

Multiple Sclerosis ◽

Systematic Review ◽

Meta Analysis ◽

Number Needed To Treat ◽

Relapsing Remitting ◽

Efficacy and safety of monoclonal antibody therapies for relapsing remitting multiple sclerosis: A network meta-analysis

Multiple Sclerosis and Related Disorders ◽

10.1016/j.msard.2018.08.026 ◽

2018 ◽

Vol 25 ◽

pp. 322-328 ◽

Cited By ~ 3

Author(s):

Xinghua Xu ◽

Sumin Chi ◽

Qun Wang ◽

Chengxin Li ◽

Bainan Xu ◽

...

Keyword(s):

Multiple Sclerosis ◽

Monoclonal Antibody ◽

Meta Analysis ◽

Efficacy And Safety ◽

Relapsing Remitting ◽

PND2 Efficacy and Safety of Disease-Modifying Therapies for the Treatment of Relapsing-Remitting Multiple Sclerosis: A Systematic Review

Value in Health ◽

10.1016/j.jval.2021.04.786 ◽

2021 ◽

Vol 24 ◽

pp. S158

Author(s):

M. Lingohr-Smith ◽

C. Deitelzweig ◽

G. Lin ◽

J. Lin

Keyword(s):

Multiple Sclerosis ◽

Systematic Review ◽

Efficacy And Safety ◽

Relapsing Remitting ◽

Disease Modifying ◽

Interferon therapy in relapsing-remitting multiple sclerosis: A systematic review and meta-analysis of the comparative trials

Journal of the Neurological Sciences ◽

10.1016/j.jns.2010.11.003 ◽

2011 ◽

Vol 302 (1-2) ◽

pp. 96-105 ◽

Cited By ~ 31

Author(s):

Brant J. Oliver ◽

Erol Kohli ◽

Lloyd H. Kasper

Keyword(s):

Multiple Sclerosis ◽

Systematic Review ◽

Interferon Therapy ◽

Meta Analysis ◽

Relapsing Remitting ◽

Relapsing Remitting Multiple Sclerosis ◽

Comparative Trials

The Effectiveness of Dimethyl Fumarate Monotherapy in the Treatment of Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis

Current Neuropharmacology ◽

10.2174/1570159x12666140115214801 ◽

2014 ◽

Vol 12 (3) ◽

pp. 256-268 ◽

Cited By ~ 13

Author(s):

Pawel Kawalec ◽

Alicja Mikrut ◽

Natalia Wisniewska ◽

Andrzej Pilc

Keyword(s):

Multiple Sclerosis ◽

Systematic Review ◽

Meta Analysis ◽

Dimethyl Fumarate ◽

Relapsing Remitting ◽

The Efficacy of Natalizumab versus Fingolimod for Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review, Indirect Evidence from Randomized Placebo-Controlled Trials and Meta-Analysis of Observational Head-to-Head Trials

PLoS ONE ◽

10.1371/journal.pone.0163296 ◽

2016 ◽

Vol 11 (9) ◽

pp. e0163296 ◽

Cited By ~ 14

Author(s):

Georgios Tsivgoulis ◽

Aristeidis H. Katsanos ◽

Dimitris Mavridis ◽

Nikolaos Grigoriadis ◽

Efthymios Dardiotis ◽

...

Keyword(s):

Multiple Sclerosis ◽

Systematic Review ◽

Meta Analysis ◽

Indirect Evidence ◽

Controlled Trials ◽

Relapsing Remitting ◽

Comparative efficacy and acceptability of disease-modifying therapies in patients with relapsing–remitting multiple sclerosis: a systematic review and network meta-analysis

Journal of Neurology ◽

10.1007/s00415-019-09395-w ◽

2019 ◽

Vol 267 (12) ◽

pp. 3489-3498 ◽

Cited By ~ 14

Author(s):

Huihui Li ◽

Fengli Hu ◽

Yanli Zhang ◽

Kai Li

Keyword(s):

Multiple Sclerosis ◽

Systematic Review ◽

Meta Analysis ◽

Comparative Efficacy ◽

Relapsing Remitting ◽

Disease Modifying ◽